Lee Bum-jae to head vaccine business unit in Merck

Published: 2012-06-13 06:56:00

Updated: 2012-06-13 06:56:00

MSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., appointed Lee Bum-Jae as its new director, responsible for taking charge of vaccine business division in the Asia-Pacific region as of June 1.

Lee Kim will manage all sales and marketing business of vaccines and female prod...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK